Maverick Simulation Solutions Ltd: Complete Analysis, Financials & Growth Potential (2026)

Apr 13th 2026
Maverick Simulation Solutions Analysis 2026

 

Maverick Simulation Solutions Ltd specialises in medical simulation technology solutions. The company was founded as Maveric Solution Inc., a 3D scanning and printing venture, in 2006. Almost a decade later, in 2019, it revamped itself and entered the medical and healthcare simulation industry.

In September 2023, it became a Public limited company. Maverick Simulations’ broad portfolio includes medical simulators like AI-powered patient simulators, an Anatomy Dissection table, task trainers and much more.

 

Key Financial Insights 2026

Particular(FY2024-25) (₹ crore)
Annual Revenue138.8
Net Profit / Loss47.8
Total Equity97
Cash Balance7.24 Crores

(Note: Figures are estimates as per publicly available reports)

 

Maverick Simulation Solutions at a Glance

Here is an overview of Maverick Simulation Solutions Limited.

ParticularsDetails
Company NameMaverick Simulation Solutions Ltd.
Founded / IncorporatedFounded in 2006, Incorporated as Public Co. on 4 Sep 2023
IndustryMedical Simulation / Healthcare Technology
FoundersAnuj Chahal & Kanika Chahal
HeadquartersDwarka, New Delhi, India
Business ModelB2B – Medical simulators & lab solutions
Company TypePublic (Unlisted)

 

History of Maverick Simulation Solutions Ltd.

Over the years, Maverick Simulation Solutions Ltd have developed as a leading medical technology solutions provider. Let’s have a look at its origin and history.

YearEvent
2006Founded as Maveric Solution Inc.
2019Shift to Healthcare Simulation
2020–2022Expansion Phase
2023Incorporated as Maverick Simulation Solutions Ltd. (Public Company).
2026Launched SIDDH (AI-powered patient simulator)

 

2006: Founded as Maveric Solution Inc.

The company was founded as Maveric Solution Inc by Anuj Chahal (Founder and Managing Director) and Kanika Chahal (Co-founder and Director). It focused on 3D scanning, reverse engineering, and prototyping for almost two decades till 2019.

2019: Shift to Healthcare Simulation

In 2019, almost a decade later, the company shifted its core business operations to healthcare simulation, introducing the Anatomage virtual dissection table in India through global collaboration.

2020-2022: Expanded its Product Portfolio

Maverick Simulation Solutions built an in-house R&D facility and launched products like LuSi & TestChest; started offering complete simulation lab solutions for institutions like AIIMS, IITs, etc.

2023: Incorporated as Maverick Simulation Solutions Ltd.

The firm was converted from private to public (Maverick Simulation Solutions Ltd.) in Sep 2023. This made the business scale for larger growth.

2006: Launched SIDDH (AI-powered Patient Simulator)

In Feb 2026, Maverick launched “SIDDH”, a life-size adult critical care patient simulator with AI-powered ultrasound, co-developed domestically.

 

Founders and Leadership

Maverick Simulation Solutions has an experienced cross-functional team combining engineering, medical, and business expertise.

Here is a brief overview of the founders of the organisation.

NameDesignationBackground & Role
Anuj ChahalFounder & Managing DirectorMechanical engineer with 20+ years of experience in product development and 3D engineering.
Kanika ChahalCo-Founder & DirectorElectrical engineer with corporate experience (ABB, HCL, Airtel).
Dr. Sunil TomarDirector (R&D)30+ years of teaching and research experience.

 

Business and Operations

Maverick operates as a B2B, solution-oriented model in the healthcare education segment.

Products: It designs and sells hardware simulators across all fidelity levels. The offerings include 40+ products. These products often incorporate AI (Artificial Intelligence) /AR(Augmented Reality)/VR (Virtual Reality) technology.

Some of the key offerings are:

  • Task trainers (suture pads, arms for IV insertion)
  • Patient mannequins
  • Full-size adult/pediatric simulators with software.
  • High-end systems (like SIDDH)

Training & Services: The company offers various courses and training programs. It supports clients post-sale with curriculum development and maintenance. Training programs offered by Maverick Simulation:

  • VentilateSim Pro: Regarding mechanical ventilation, lung-protective ventilation strategies
  • NurseSim Pro: Advanced Simulation-based training for nurses
  • IVF Sim Pro: Learning advanced clinical skills
  • FaceSim Pro: Upgradation of dermatology skills

 

Financial Overview

Here is a brief financial overview of Maverick Simulation.

Financial Performance (FY24-FY25)

Particulars(FY 2023-FY24) (₹ Crore)(FY 2024-FY25) (₹ Crore)
Revenue14.2136.3
EBITDA1.1261.34
PAT0.9448

 

Balance Sheet Snapshot

Particulars(FY 2023-FY24) (₹ Lakhs)(FY 2024-FY25) (₹ Lakhs)
Non-Current Assets883.39756.06
Current Assets7,833.7715,588.70
Total Assets8,717.7616,345
Total Equity2,556.459,700
Non-Current Liabilities-1,107.13
Current Liabilities6,160.715,537.47
Total Liabilities8,717.7616,345

 

Cashflow Statement

Particulars(FY 2023-FY24) (₹ Lakhs)(FY 2024-FY25) (₹ Lakhs)
Operating Cash Flow-2,039.33-2,100.10
Investing Cash Flow-834.76-1,129.46
Financing Cash Flow3,231.123,597
Net Cash change357.03367
Opening Cash & Cash Equivalents-357.03
Closing cash position357.03724.12

(Note: The Figures presented are estimates based on publicly available reports.)

 

Previous Funding History

Maverick Simulation Solutions Limited has not undergone any formal VC funding or public capital raise. It has been financed through:

  • Promoter Capital: Initial funding from founders’ investments during the private era (as Maveric Solutions).
  • Internal Reinvestment: The company has used the profits to strengthen its research and development expansion. This means the company remains founder‐financed. Its business scaling relies on organic growth and project credit, not on equity dilution.

 

Business USPs

Below are some key business USPs of Maverick Simulation Solutions Ltd.:

  • “Made-in-India” Innovation: Maverick Simulation Solutions Limited is best known as an Indian manufacturer of advanced medical simulators. It also collaborates with global leaders to maintain and ensure international quality standards.
  • Complete Simulation Ecosystems: Unlike standalone device vendors, Maverick delivers end-to-end training programs to make the learner well-versed with their simulators and products.
  • Tech Integration: The company involves modern tech, AI, AR/VR, and cloud analytics in its systems. Example: The new SIDDH simulator includes AI-powered ultrasound and real-time feedback.
  • Institutional Partnerships: Collaborations with AIIMS hospitals and other institutions enhance credibility and product development. The adoption by government medical colleges provides a strong base for the company to gain authority and trust in the industry.

 

Future Growth Plans

Maverick’s management has outlined ambitious expansion plans in recent years:

  • R&D Investment: Last year, in 2025, the company announced that it had budgeted an estimated amount of ₹50 Crore for R&D this year to fund next-gen simulators (integrating AI/ML) and new modules (e.g. pediatric, tele-simulation). In April 2026, it launched SIDDH (adult patient simulator). As per reports, it is a 65 kg full-body simulator that is aimed to replicate real-world medical scenarios and a real-time physiological response system.
  • Brand Building: The company is actively working for “Made in India” leadership and engaging academic partners. In various recent public appearances, the leadership team has directed that in the coming years, Maverick aims to become a national player in medical simulation. They aim to make it “not just a consumer but a creator and exporter” of simulation tech.

 

Recent Market Trends

India’s medical simulation market is growing rapidly for competency-based medical education, expansion of skills, and the need for safe, hands-on clinical training.

Maverick is well-positioned in this environment with its “Made in India” approach. The February 2026 launch of SIDDH directly addresses these trends. It is well supported by its vision to invest ₹50 crore in R&D focus and its presence as the medical simulator supplier among 100+ reputed medical institutions.

 

Disclaimer: The information provided is based on publicly available data, industry reports, and company announcements. Market size, growth rates, and projections are estimates and may vary across sources. Future performance depends on multiple factors, including regulatory changes, competition, and execution risks. Investors should conduct their own research before making any investment decisions.

 

Unlisted Shares
Unlisted Shares

Got a question for us?

Scroll Top ↑
unlistedkraft
Contact Us